UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date
of report (Date of earliest event reported):
(Exact Name of Registrant as Specified in Its Charter)
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
(Address of principal executive offices) | (Zip Code) |
Registrant’s
telephone number, including area code:
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol | Name of each exchange on which registered | ||
None | None | None |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 1.01 Entry into a Material Definitive Agreement.
From May 10, 2022 to September 9, 2022, Sigyn Therapeutics, Inc. (the “Company”) issued Original Issue Discount Convertible Debentures (the “Debentures”) in an aggregate principal amount of $220,420 to Brio Capital Master Fund Ltd. (“Brio”). On April 9, 2024, Brio converted such Debentures into 292.4 shares of its Series B Convertible Preferred Stock (the “Series B Preferred Stock”).
From June 23, 2020 to June 1, 2022, the Company issued an aggregate principal amount of $621,000 to Osher Capital Partners, LLC (“Osher”). On April 10, 2024, Osher converted such Debentures into 823.86 shares of its Series B Preferred Stock.
Each share of Series B Preferred Stock converts into 125.63 shares of the Company’s common stock, subject to antidilution adjustments for any stock splits and recapitalizations, and for issuances of additional shares at an issue price of less than the conversion ratio.
Brio and Osher agreed to amend an additional $110,000 and $275,000, respectively, of Debentures to extend the maturity dates of such Debentures to March 31, 2025 in return for an increase in principal amount of such Debentures to $125,000 and $316,350, respectively, and provide for the automatic conversion of a total of $1,856,566 aggregate principal amount of Debentures held by them into additional shares of the Series B Preferred Stock which are convertible into the same number of shares of common stock as previously provided in the terms of the Debentures upon the listing of the common stock on NASDAQ.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SIGYN THERAPEUTICS, INC. | ||
Date: April 16, 2024 | By: | /s/ James A. Joyce |
James A. Joyce, Chairman and CEO |
Cover |
Apr. 16, 2024 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Apr. 16, 2024 |
Entity File Number | 333-204486 |
Entity Registrant Name | SIGYN THERAPEUTICS, INC. |
Entity Central Index Key | 0001642159 |
Entity Tax Identification Number | 47-2573116 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 2468 Historic Decatur Road |
Entity Address, Address Line Two | Suite 140 |
Entity Address, City or Town | San Diego |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92106 |
City Area Code | 619 |
Local Phone Number | 368.2000 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | true |
-8?20$3;8T.P6BP^
M0"X99K>]9!:G
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end